Clinical trials
Phase 2 Endometriosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
88 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 3 |
| 2004 | 1 |
| 2005 | 7 |
| 2006 | 2 |
| 2007 | 4 |
| 2008 | 3 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 5 |
| 2013 | 3 |
| 2014 | 3 |
| 2016 | 5 |
| 2017 | 5 |
| 2018 | 2 |
| 2019 | 8 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 7 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 57 |
| Unknown status | 9 |
| Terminated | 9 |
| Withdrawn | 6 |
| Active, not recruiting | 3 |
| Recruiting | 2 |
| Not yet recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 6 |
| Boston Children's Hospital | 5 |
| AbbVie | 4 |
| Abbott | 4 |
| Kissei Pharmaceutical Co., Ltd. | 4 |
| Repros Therapeutics Inc. | 4 |
| Cairo University | 2 |
| Enteris BioPharma Inc. | 2 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2 |
| KU Leuven | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endometriosis | 88 |
| Pelvic Pain | 20 |
| Dysmenorrhea | 11 |
| Infertility | 7 |
| Dyspareunia | 6 |
| Pain | 6 |
| Chronic Pain | 2 |
| Disease | 2 |
| Uterine Diseases | 2 |
| Adenomyosis | 1 |
Trials
Showing 51 to 75 of 88. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.